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Better-performing younger adults typically express greater brain
signal variability relative to older, poorer performers. Mechanisms
for age and performance-graded differences in brain dynamics
have, however, not yet been uncovered. Given the age-related
decline of the dopamine (DA) system in normal cognitive aging,
DA neuromodulation is one plausible mechanism. Hence, agents
that boost systemic DA [such as d-amphetamine (AMPH)] may help
to restore deficient signal variability levels. Furthermore, despite
the standard practice of counterbalancing drug session order
(AMPH first vs. placebo first), it remains understudied how AMPH
may interact with practice effects, possibly influencing whether
DA up-regulation is functional. We examined the effects of AMPH
on functional-MRI–based blood oxygen level-dependent (BOLD)
signal variability (SDBOLD) in younger and older adults during a
working memory task (letter n-back). Older adults expressed
lower brain signal variability at placebo, but met or exceeded
young adult SDBOLD levels in the presence of AMPH. Drug session order
greatly moderated change–change relations between AMPH-driven
SDBOLD and reaction time means (RTmean) and SDs (RTSD). Older adults
who received AMPH in the first session tended to improve in RTmean
and RTSD when SDBOLD was boosted on AMPH, whereas younger and
older adults who received AMPH in the second session showed either a
performance improvement when SDBOLD decreased (for RTmean) or no
effect at all (for RTSD). The present findings support the hypothesis that
age differences in brain signal variability reflect aging-induced changes
in dopaminergic neuromodulation. The observed interactions among
AMPH, age, and session order highlight the state- and practice-depen-
dent neurochemical basis of human brain dynamics.
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Human brain signals are characteristically variable and dy-namic, at a variety of timescales and levels of analysis (1, 2).
For decades, age-related cognitive deficits have been conceptu-
alized as due to various forms of “noisy,” inefficient neural
processing (3, 4). However, the preponderance of available
neuroimaging work on brain signal variability and aging indicates
that healthy, higher performing, younger adults typically express
more signal variability across trials and time in a variety of cor-
tical regions relative to older, poorer performers (2, 5–7). The-
oretical and computational explanations of this finding include
notions such as flexibility/adaptability, dynamic range, Bayesian
optimality, and multistability (2), but empirically supported
mechanisms for age and performance-graded differences in hu-
man brain signal dynamics are not yet available. Dopamine (DA)
neuromodulation may provide one such mechanism.
DA neuromodulation is a leading mechanistic candidate for
age-related cognitive losses (8–10). Concurrent with substantia
nigra and ventral tegmental DA neuron loss, D1 and D2 receptor
densities reduce notably from early to late adulthood across various
subcortical and cortical regions (9–11). However, it is not yet known
whether DA affects brain signal variability in relation to age and
performance. DA is generally considered a neuromodulator sup-
porting both system stability (e.g., signal “fidelity,” “precision,” and
“signal-to-noise ratio”) and flexibility/adaptability (8–10, 12–14).
Single-unit and multiunit computational models demonstrate that
simulated aging-related DA losses can yield more inefficient stim-
ulus detection, lower average neuronal firing pattern, and de-
differentiation of neural responses in the face of varying stimuli (8).
Importantly, adding noise to “older” DA-degraded neurons can
improve their relatively poor stimulus detection properties (15).
This neurocomputational result highlights the potential benefits of
explicitly boosting dynamics in DA-degraded, aging neural systems.
DA may influence in vivo brain dynamics in a variety of ways.
DA neurons exhibit dominant low-frequency tonic firing patterns
along with intermittent phasic bursts (16), resulting in moment-
to-moment variation in neural signaling. At millisecond and
second levels, DA release also operates via shorter and longer-
term facilitation and depression (e.g., so-called “kick-and-relax”
dynamics, 17, 18) that affect subsequent DA-dependent spike
dynamics. Mouse data highlight that DA-deficient animals
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display a complete lack of phasic bursting activity (variable on
and off periods of spike trains), exhibiting only single spikes with
long interspike intervals (19); notably although, bursting activity in
these DA deficient animals can be restored toward normal levels
via DA agonism (19). In addition, in line with the contention that
brain signal variability can index a healthy neural system (2), animal
models indicate that trial-to-trial variability in DA release appears
to increase, rather than decrease, with increasing task proficiency
(20). From this work, it is plausible that DA may also affect in vivo
brain signal variability and its cognitive correlates in humans. Given
that normal aging is associated with DA decline and poorer cog-
nitive performance, and that poorer cognitive performance often
characterizes generalized aging-related reductions in brain signal
variability, lower age-related brain signal variability could reflect
DA system degradation. Accordingly, we predicted that pharma-
cological agents that boost systemic DA, such as amphetamine
(AMPH), would restore deficient signal variability levels in older
adults. Extant studies have examined the effect of DA agonists on
average blood oxygen level-dependent (BOLD) signal responses
and cognition (13, 21, 22); however, the effects of DA agonists on
BOLD signal variability and cognition, and the moderation of
these effects by adult age, have not been investigated thus far.
In the present study, we examine the multivariate effects of AMPH
on BOLD signal variability and cognitive performance in younger
and older adults during an n-back working memory (WM) task.
Given impoverished signal variability (5–7) and DA levels (9, 10) in
normal aging, we predicted that older adults’ BOLD variability, on
average, would increase more on AMPH relative to placebo than
that of younger adults. We used mixed modeling to examine whether
AMPH-related changes in SDBOLD predict AMPH-related changes
in performance within individuals, and whether a higher average level
of SDBOLD coincides with higher average performance across in-
dividuals. In particular, we hypothesized that older adults (typified by
lower DA, less BOLD variability, and lower cognitive performance)
would show increased BOLD variability and improved cognitive
performance under AMPH. Furthermore, recent evidence suggests
that drug session order may influence the robustness of drug-related
changes in performance (e.g., ref. 23); we thus explored whether
administration order (i.e., AMPH first vs. placebo first) would
moderate the effects of AMPH on SDBOLD, cognitive performance,
or both, thus pointing to state- and practice-dependent aspects of
human brain dynamics, and adult age differences therein.
Results
Multivariate Model Linking SDBOLD to AMPH, Age Group, and Task.
We first ran a multivariate partial least-squares (PLS) model (see
Methods and Supporting Information for details) that explicitly
linked SDBOLD to AMPH, age group, and task condition. We
found a single robust latent variable (LV) (cross-block covariance,
60.86%; permuted P < 0.00001) representing this relationship.
Fig. 1 contains a plot of PLS brain scores for each task condition,
AMPH condition, and age group [error bars in Fig. 1 represent
95% bootstrapped confidence intervals; a lack of overlap in in-
terval indicates a reliable difference (24)]. The associated brain
pattern (Fig. 1) highlights a unidirectional effect; the higher the brain
score, the higher the level of brain signal variability in yellow/red
regions. Under placebo, younger adults (YA) expressed more
SDBOLD in all task conditions than did older adults (OA; see also SI
Results and Fig. S1 for confirmation of a placebo-only model sup-
porting this effect). This is in accordance with our previous studies
(5–7). However, OA SDBOLD levels dramatically increased under
AMPH, whereas YA expressed a more modest increase only at 2-
back. For YA and OA on AMPH, SDBOLD appeared to increase
with increasing task difficulty until the 2-back condition, and either
leveled off or tapered at 3-back; there were no differences between
task conditions for OA at placebo. This lack of difference in SDBOLD
levels between task conditions in older adults is also in line with
previous work (7). Interestingly, under AMPH, older adults became
more differentiated across conditions (at least when comparing fix-
ation and 1-back to the 2-back condition).
Spatially, our model revealed several regions typical of WM
studies (25, 26), including bilateral middle frontal gyri [dorsolateral
prefrontal cortex (DLPFC)], left supplementary motor area (SMA),
and bilateral posterior parietal cortices (postcentral gyri). Striatal
dopaminergic areas (13, 14, 27) that modulated in SDBOLD were
also evident in a left putamen cluster that extended into left caudate
nucleus (see Fig. 1 for relevant slices). Other prominent regions
included right parahippocampal gyrus (extending into bilateral
thalamus and surrounding regions), middle and superior temporal
gyri, and inferior occipital gyri. A complete list of bootstrapped
cluster peaks (Table S1, model 1), and a complete axial view of
brain slices (Fig. S2) can be found in Supporting Information.
Although it appears from Fig. 1 that OA SDBOLD levels on
AMPH exceed that of YA at both placebo and AMPH, individual
slopes reveal a more detailed story. For example, at 2-back, no
older adult exceeded the level of the most variable younger adult
(Fig. S3). The highest brain scores are similar in both groups, with
most OA showing positive slopes on AMPH, and YA showing a
mix of positive and negative slopes (and a slight upward mean shift).
The OA trend of the slopes is such that those with higher SDBOLD
at placebo tended to stabilize or slightly reduce their SDBOLD levels
on AMPH, whereas those with lower SDBOLD at placebo tended to
increase SDBOLD levels on AMPH. The fact that more older adults
increased their SDBOLD levels on AMPH expressed itself as a larger
upward AMPH-related group shift in Fig. 1. Such slope effects are
consistent with the generic notion of a dopamine-related inverted-
U curve, in that those with lower baseline levels of SDBOLD appear
to increase the most in SDBOLD on AMPH. Unsurprisingly, sta-
tistical examination of this effect indicated that placebo SDBOLD
indeed negatively and strongly correlated with AMPH-related
change in SDBOLD for each age group across experimental con-
ditions (Fig. S4).
Mixed Models of SDBOLD. The current PLS model represents multi-
variate, latent-level relations among BOLD, AMPH, task, and age
Fig. 1. PLS model of relation between SDBOLD, Age Group, AMPH, and Task
Condition. Higher brain scores reflect higher BOLD signal variability. Error bars
represent bootstrapped 95% confidence intervals (1,000×with replacement). Brain
images are plotted in neurological orientation (left is Left). AMPH, amphetamine;
BSR, bootstrap ratio.
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group. However, such models do not explicitly quantify the unique
importance of each effect in the solution. Subsequent mixed models
(SI Methods) can help parse these various effects, while flexibly ac-
counting for degrees of freedom and model covariances at within-
(i.e., AMPH, Task) and between- (i.e., Age Group) subject levels (28).
Results revealed robust AMPH [F(1,429.97) = 52.80, P = 1.75 × 10
−12]
and AMPH ×AgeGroup [F(1,429.97) = 42.15, P = 2.33 × 10
−10] effects
(Table S2, model 1). Importantly, Task offered no unique predictive
variance. This pattern establishes AMPH as the primary within-sub-
ject modulator of SDBOLD in this study. Notably, we found no evi-
dence that these effects were driven by physiological artifacts (for
details, see SI Methods and SI Results, and Table S2, model 2).
Mixed Models Linking AMPH-Related Modulations in SDBOLD to WM
Performance. Another goal of the present study was to predict
WM performance [reaction time means (RTmean) and SDs
(RTSD); SI Methods] from SDBOLD (using the PLS brain scores
shown in Fig. 1) in the context of AMPH. Because within- and
between-person levels were present for both SDBOLD (the key
independent variable) and WM (the dependent variable), we
used mixed models that separately estimated within- and be-
tween-person relations between SDBOLD and WM performance
(SI Methods). Importantly, for all related model runs, we ex-
cluded Task Condition given its lack of unique effects on
SDBOLD in the initial mixed model (Table S2, model 1). Fur-
thermore, in light of evidence suggesting that drug session order
may influence the robustness of drug-related changes in perfor-
mance (e.g., ref. 23), we also investigated the effect of Session
Order (placebo/AMPH vs. AMPH/placebo).
Of primary importance for the current study, we first fit
within-subject–only models to capture whether AMPH-related
changes in SDBOLD brain scores (SDBOLD_within) predicted
AMPH-related changes in WM (RTmean_within and RTSD_within;
models were run separately for each behavioral metric). For the
RTmean_within model, results revealed a key three-way interaction
between Age Group, Session Order, and SDBOLD_within
[F(1,95.57) = 4.72, P = 0.03; see Table S2, model 3, for all other
main effects and lower-level interactions]. This effect (Fig. 2,
Upper) demonstrates that the relation between AMPH-related
changes in SDBOLD and AMPH-related changes in RTmean dif-
fers greatly by Age Group and Session Order. Among those
receiving AMPH in the first session, RTmean performance im-
proved in the OA group when SDBOLD was higher on AMPH
(simple slope: r = 0.37); YA showed no effect (simple slope: r =
−0.05). Conversely, for those who received AMPH in the second
session, both YA (simple slope: r = −0.44) and OA (simple
slope: r = −0.60) groups showed improved RTmean when SDBOLD
was lower on AMPH relative to placebo. Accordingly, post hoc
analyses revealed a significant slope difference between first session
YA and OA groups [Age Group × SDBOLD_within interaction,
F(1,56.27) = 4.10, P = 0.05], but not between second session YA and
OA groups [F(1,37.96) = 0.57, P = 0.46]. For the RTSD_within model,
we also found an Age Group × Session Order × SDBOLD_within
interaction [F(1,81.97) = 7.31, P = 0.01; see Table S2, model 4, for all
model effects]. Here (Fig. 2, Lower), only the first-session OA group
showed any notable slope (simple slope: r = 0.48), and in exactly the
same manner as for RTmean_within; when SDBOLD increased on
AMPH, first-session OA exhibited more consistent RT perfor-
mance. Predictably, follow-up analyses again revealed a significant
slope difference between first session YA and OA groups [Age
Group × SDBOLD_within interaction, F(1,42.58) = 10.01, P = 0.003],
but not between second-session YA and OA groups [F(1,37.31) =
0.23, P = 0.64]. Finally, we found no reliable between-subject
(“level–level”) model relations between SDBOLD and RTmean or
RTSD (Table S2, models 5 and 6). Behavior-only model results
(Table S2, models 7 and 8; and Fig. S5) and behavioral descriptive
statistics (Table S3) can also be found in SI Methods and SI Results.
A Lack of AMPH-Driven MeanBOLD Effects.As in past work (5, 6, 29),
we reran the same PLS model as above, but this time using
meanBOLD as the voxel measure to compare the relative utility
of SDBOLD and meanBOLD. Although we found a clear and
predictable differentiation between fixation and n-back conditions
(single LV; cross-block covariance, 58.23%; permuted P < 0.00001),
Fig. 2. Relation between AMPH-related changes in
SDBOLD PLS brain scores (SDBOLD_within) and (i) AMPH-
related changes in reaction time means (RTmean_within;
Upper) and (ii) SDs (RTSD_within; Lower), moderated by
age group and drug session order. Each subject in each
group is represented by three points in the scatters, one
for each n-back condition. Positive SDBOLD values indicate
higher BOLD signal variability on AMPH relative to pla-
cebo. AMPH, amphetamine. Simple slope P values: (a)
P = 0.039; (b) P = 0.672; (c) P = 0.005; (d) P = 0.412; (e)
P = 0.001; (f) P = 0.0002; (g) P = 0.682; (h) P = 0.311.








AMPH did not modulate meanBOLD, either within or across age
groups, precluding the need to further test models linking AMPH-
modulated meanBOLD to AMPH-modulated cognition. Full
model results can be found in Fig. S6 (PLS bar plots and spatial
pattern), Table S2 (model 9, for mixed-model results), and Table
S1 (model 2, for bootstrapped cluster peaks).
Discussion
We used multivariate and mixed models to gauge relations between
BOLD signal variability, AMPH, age, and WM performance. We
obtained two key findings: First, our results support the hypothesis
that adult age differences in brain signal variability reflect aging-
induced changes in dopaminergic neuromodulation. Second, the
substantial interactions between AMPH effects and session order
highlight the state- and practice-dependent neurochemical basis
of human brain dynamics. These findings are discussed in turn.
The Influence of AMPH on Age-Related SDBOLD.As predicted, AMPH
boosted low BOLD signal variability levels in older adults across
conditions. Given increasing evidence of higher overall SDBOLD
levels in young, high performers in previous work (2, 5–7, 30), we
assumed the average YA to begin (at placebo) nearer to optimal
signal variability levels, and that the average OA would rise to-
ward YA levels. Accordingly, individual slopes revealed that the
majority of OA increased in SDBOLD on AMPH (especially those
with the lowest levels of SDBOLD at placebo), whereas YA
showed a mix of positive and negative slopes (resulting in a net
zero group change). This pattern of results (and our subsequent
statistical examination of this effect; Fig. S4) is consistent with
the general notion of an inverted-U–shaped DA curve (10, 13,
14), now linking DA and SDBOLD. These AMPH-related effects
were found within several brain regions typically associated with
WM in mean BOLD activation studies (25, 26) and/or DA (13,
14, 27), including bilateral middle frontal gyri (DLPFC), left
SMA, bilateral posterior parietal cortices, and striatum (left
putamen/left caudate nucleus). However, no clear AMPH-
related modulation of meanBOLD existed for these or any other
brain areas in our data, again demonstrating the remarkable
sensitivity of BOLD signal variability measures in neuroimaging
research (5, 6, 29). AMPH-related regional modulations of
SDBOLD extended well beyond typical DA projections, pre-
sumably reflecting upstream or downstream effects of DA-
related modulation on brain dynamics (e.g., cerebellum, bilateral
motor, and inferior occipital cortices), suggesting that DA-
related modulation of SDBOLD is widespread and encompasses a
broad range of stimulus processing and response execution op-
erations. Notably, AMPH effectively increased SDBOLD in older
adults in various regions noted in previous work to show reduced
signal variability with age (5–7), including bilateral DLPFC,
posterior parietal, and primary visual cortices. However, past
work (5, 6, 31) has also sometimes found that select subcortical
regions exhibit the inverse effect, such that BOLD signal vari-
ability is higher in older adults. Importantly, these previous
studies have been primarily between-subject in nature. In the
current study, AMPH increased SDBOLD in older adults in all
robust regions (cortical and subcortical) in the same direction,
within-person. The only other aging-related within-subject study
of BOLD signal variability we are aware of is our own (7), which
showed that younger adults only increased in SDBOLD level from
fixation to task (in a large set of cortical and subcortical regions) to
a greater extent than older adults. Thus, although regional points
of overlap (or lack thereof) are highly useful to consider, we
caution against directly anticipating direct overlap across between-
and within-subject results regarding age-related BOLD signal
variability. In particular, in this study, within-subject effects sta-
tistically dominated over between-subject effects, suggesting that
direct manipulation of SDBOLD provides a highly sensitive ap-
proach for gauging age-related signal variability (Fig. 1).
One possible mechanism for AMPH-induced increases in
SDBOLD in older adults (and in those with lower baseline
SDBOLD levels) relates to phasic, oscillatory bursting activity in
neurons (trains of spikes followed by off periods that may be
rhythmic or arrhythmic), which provides a natural moment-
to-moment source of variability. Paladini et al. (19) found that
neurons in mice with healthy DA systems exhibited classic
bursting activity, whereas DA-deficient mice displayed a com-
plete lack of bursting, showing only single spikes with long
interspike intervals. Critically, the authors successfully increased
bursting activity in these DA-deficient animals via DA agonism.
This finding directly informs the current results. Our presumably
DA-degraded older adults (9, 10) may therefore exhibit lower
SDBOLD levels due to a lack of DA-driven bursting activity;
however, via AMPH, we may have increased bursting in older
adults, yielding higher SDBOLD levels. It is thus possible that
sparser spiking activity in DA-degraded systems is insufficient to
drive BOLD fluctuations overall. Beyond bursting, further de-
lineation of precisely how AMPH may drive DA-based brain
signal variability requires specific targeting of D1 and D2 systems.
One prevailing view (14, 32) assumes that the D1 system is most
important for systemic stabilization and WM maintenance,
whereas D2 signaling enables systemic flexibility and WM up-
dating (13, 33, 34). The task used in this study was indeed a
WM updating task, and given that brain signal variability may be
a reflection of systemic flexibility (2), the D2 system may be more
relevant in this context than D1. Should neuronal bursting (19)
provide a basis for DA-driven changes in SDBOLD, this same
mechanism could influence systemic flexibility via D2 receptors.
However, as AMPH affects both D1 and D2 functions concur-
rently (35), simultaneous PET-fMRI may be required to link
both systems to SDBOLD, ideally across multiple sessions in which
D1 (e.g., [
11C]SCH 23390)- and D2 (e.g., raclopride, fallypride)-
specific ligands are administered separately.
AMPH-Related Relations Between SDBOLD and WM Performance as a
Function of Age and Drug Administration Order. We also applied a
series of mixed models in our study to link SDBOLD to within-
and between-person WM performance in relation to AMPH.
Of particular importance were significant “change–change” re-
lations between AMPH-related SDBOLD and AMPH-related RT
(mean and SD) during n-back. Critically, we found that age
group and order of AMPH administration drove the association
between AMPH-related modulations in SDBOLD and RT. This
means that whether AMPH-related increases in SDBOLD in
cortical (e.g., DLPFC) and subcortical (e.g., striatum) regions
noted above were functional for performance depended on age
and session order. Older adults who received AMPH in the first
session tended to improve in both speed and RT consistency
when SDBOLD was greatly boosted on AMPH. Conversely, those
who received AMPH in the second session showed either greater
performance improvements in the presence of modest re-
ductions in SDBOLD (for RTmean) or no effect at all (for RTSD).
How is it possible that AMPH administration order (a typical
nuisance regressor) plays such a pivotal role? Order counter-
balancing in typical pharmacological imaging studies effectively
intermixes practice effects with drug order, and potentially
modulates the brain–behavior effects researchers seek to iden-
tify. Although practice effects are well acknowledged in the
broader DA and cognitive literatures (36–38), understanding of
these effects is limited. DA is typically associated with various
forms of learning (9, 10, 13, 14, 39), but data on how DA
modulation interacts with practice remain sparse. Of the few
available studies, Owesson-White et al. (20) demonstrated that
DA release increases linearly with reward-based lever press
practice in rats. Accordingly, one mechanism to support our
findings may be that, by allowing practice, we shifted participants
along an inverted-U–shaped DA-performance curve (13) by
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increasing baseline DA release. The subsequent administration
of a DA agonist (AMPH) when participants are in a more practiced
state (as in the placebo-AMPH group) may then have productive or
counterproductive effects, to the extent one is already near the apex
of the curve. Conversely, those who receive AMPH with limited
task practice arguably reflect a purer example of the influence of
AMPH alone. Accordingly, for the first-session older group (Fig. 2),
those exhibiting the greatest AMPH-related increases in SDBOLD
indeed showed the greatest improvements in RTmean and RTSD.
However, in this AMPH-placebo group, practice effects un-
avoidably worked against AMPH-related modulations; as practice-
related improvements are expressed at retest (placebo), any AMPH-
related effects could then be attenuated due to practice-related in-
creases in DA release (20). Although practice effects are unlikely to
confound AMPH effects completely (34), a four-cell study design
(placebo/placebo, placebo/drug, drug/placebo, drug/drug) may be
needed to separate within-subject practice from drug effects. Al-
though some pharmacological studies have abandoned within-subject
designs altogether (in favor of between-subject–only approaches) to
guard against potentially problematic practice effects (40, 41), within-
subject designs remain a prerequisite for observing drug-related
changes in brain activity or performance. The present results show
that taking a close look at practice effects in pharmacological imaging
research may foster rather than hinder our understanding of
DA neuromodulation.
State-dependent learning may be yet another angle from which to
understand the importance of drug administration order when
interpreting DA-driven relations between brain dynamics, age, and
cognitive performance. State-dependent learning is a phenomenon in
which learning (or practice) is optimally expressed when one’s current
state (e.g., on drug) matches the state in which the learning occurred
(42). In principle, within-subject placebo vs. drug designs could in-
herently create a “state mismatch” by only exposing participants to
each drug state (placebo and drug) once, a problem compounded by
the researcher’s decision to deliberately counterbalance the order of
that mismatch. Unsurprisingly then, drug effects on brain and be-
havior could potentially skew or even invert, depending on whether
learning occurred on or off drug. In the current study, this could be
particularly important for the AMPH-placebo group, who learned
the n-back task under drug, but were retested under placebo. In
combination with practice effects working against drug effects (as
noted above), the AMPH-placebo group also undergoes a state
mismatch. Consequently, the concurrent AMPH-related gains in
SDBOLD, RTmean, and RTSD shown in older adults (and lack thereof
in younger adults) may be underestimated. Remarkably, in a
striking and rare example of how drug administration order (and
concomitant state-dependent learning) can greatly impact drug-re-
lated changes in human task performance, a recent study of Par-
kinson’s patients (23) examined retention of daily motor learning in
relation to levodopa (L-dopa) for (i) an “On–Off” group, who re-
ceived daily L-dopa the first week but none the following week; and
(ii) an “Off–Off” group, who were off L-dopa for both weeks.
During the second week, the On–Off group demonstrated a re-
markable loss of practice-related gains in motor performance that
they achieved in the first week, whereas the Off–Off group main-
tained all performance gains over sessions. Thus, the On–Off group
underwent an explicit mismatch that affected subsequent perfor-
mance in the presence of ongoing practice. Although the present
study takes a first step by highlighting the importance and potential
driving forces (i.e., practice, state-dependent learning) behind the
effects of drug administration order, expanding the four-group study
design proposed above (placebo/placebo, placebo/drug, drug/pla-
cebo, drug/drug) to also include multiple testing sessions (e.g.,
for the placebo/drug group, three placebo sessions followed by
three drug sessions) would help address the effects of task practice
and state-dependent learning, and in turn would elucidate key new
parameters for future model development of DA-based relations
between brain dynamics, age, and cognition.
Conclusion. The current data provide evidence for AMPH-related
changes of SDBOLD levels in relation to aging and working mem-
ory. Older adults were capable of expressing or even surpassing
younger adult levels of SDBOLD in the presence of a DA agonist
(AMPH), providing a first link between manipulation of DA levels,
brain dynamics, and age. We also found robust relations between
AMPH-driven RT and SDBOLD levels, but only when drug ad-
ministration order was considered. Accordingly, we encourage re-
searchers pursuing related pharmacological imaging studies to
consider session order as an inherently interesting moderator when
linking DA, age, cognition, and brain function. To the extent that
pharmacological DA studies suffer from the file drawer problem
(43), drug administration order may be one culprit in zeroing out
inverse behavioral/brain effects resulting from session order. In the
present study, this inversion was reflected in RT-SDBOLD relations,
serving as a springboard for future work seeking to elucidate the
state- and practice-dependent neurochemical basis of brain signal
dynamics and its developmental and cognitive correlates (2).
Methods
Participants and Procedure. Our sample (n = 62) consisted of 40 younger [YA;
age range, 20–30 y; mean (M) ± SD, 25.00 ± 2.95 y; 22 females; years of edu-
cation, 16.4 ± 3.1] and 22 older [OA; age range, 60–70 y; M ± SD, 63.91 ± 2.77 y;
12 females; years of education, 15.4 ± 3.8] adults. All participants were right-
handed, with normal or corrected-to-normal vision, and reported to be psy-
chiatrically and neurologically healthy. All OA were nondemented, community
dwelling, and scored ≥28 points on the Mini-Mental Status Examination (44).
The Ethics Committee of the State of Berlin approved the study (EudraCT
number 2006-002671-40), and written informed consent was obtained from
each participant. All participants received financial reimbursement. In a double-
blind, counterbalanced (for order of receiving placebo/AMPH) design, partici-
pants underwent testing/fMRI scanning on two occasions (1 wk apart), one in
which a physician administered a placebo (sugar pill), and another in which they
administered low-dose AMPH (0.25 mg/kg body weight). Otherwise, the pro-
cedure was identical for the two sessions. Two hours before scanning (to ap-
proximate the expected peak AMPH concentration), participants received
placebo or AMPH. About 90 min after pill ingestion (and about 30 min before
scanning), blood was drawn to later verify serum levels using gas chromatog-
raphy. Blood pressure and pulse were taken immediately before and 30 min
after pill ingestion, and immediately before and after the scanning session.
MRI Task, Acquisition, and Data Preprocessing.
Fixation and cognitive task blocks. While undergoing fMRI, participants per-
formed a letter n-back task (blocked-design) adjusted to reduce switch costs in
older participants (30). Participants were asked to compare a currently pre-
sented single letter with the letter seen one, two, or three letters earlier (i.e.,
1-, 2-, and 3-back conditions, respectively). We acquired three runs per par-
ticipant. Each run consisted of two successive blocks for each condition, with
each task block alternating between 20-s-long fixation blocks. We randomized
the order of conditions across runs. Fifteen letters were presented during each
condition block, resulting in 14 1-back trials, 13 2-back trials, and 12 3-back
trials in each block (total number of trials was 84, 78, and 72, respectively). Each
block began with 5,000-ms presentation of the condition cue (specifying 1-, 2-,
or 3-back). Each letter stimulus was presented for 1,500 ms, separated by a 500-
ms fixation cross (a total of 14 fixation crosses were presented in each block).
Participants responded “yes” (i.e., the current letter is the same as the n-back
letter) or “no” (the current letter is not the same as the n-back letter) in a two-
button forced-choice manner. Before scanning, participants were verbally
instructed about the task, practiced three runs, and received feedback on
their performance.
MRI scanning and preprocessing. Whole-brain functional MRI data were collected
using a1.5-T SiemensVisionMRI systemwith a standard echoplanar imaging (EPI)
sequence [repetition time (TR)/echo time (TE), 2,500/40 ms; flip angle, 90°; voxel
size, 4 × 4 × 4.6 mm; interslice gap, 0.15; 26 slices acquired in ascending order
approximately axial to the bicommissural plane]. Three dummy volumes pre-
ceded each of the three experimental runs to achieve a steady state of tissue
magnetization. Each run lasted about 5 min. Two structural scans (proton-den-
sity–weighted sequence: TR/TE, 4,350/15 ms; flip angle, 180°; 252 × 256 matrix;
1 × 1 × 4-mm voxel size; and a sagittally oriented high resolution T1-weighted
sequence: TR/TE, 20/5 ms; flip angle, 30°; matrix, 256 × 256; voxel size, 1 mm3)
were acquired in the same orientation as the functional EPIs to aid coregistration
of the functional images. fMRI data were preprocessed with FSL 5 (45, 46).
Preprocessing included the following: motion correction with spatial smoothing








(8-mm full-width at half-maximum Gaussian kernel) and high-pass filtering (σ =
108 s). Registration of functional images to high-resolution participant-specific
T1 images, and from T1 to 2-mm standard space (MNI 152_T1) was carried out
using FLIRT. We then masked the functional data with the GM tissue prior
provided in FSL (thresholded at probability > 0.37). Extended preprocessing steps
were also performed to further reduce data artifacts (5–7, 29), which included
ICA denoising (29) and PHYCAA+ (47); see SI Methods for details.
Data Analyses.
Behavior. All trials more than ±3 SDs from within-person means on each task
condition were dropped before computing reaction time means (RTmean)
and SDs (RTSD) for each subject and n-back level.
Calculation of SDBOLD. We first performed a block-normalization procedure to
account for residual low-frequency artifacts. We normalized all blocks for
each condition such that the overall 4D mean (x*y*z*time) across brain and
block was 100. For each voxel, we then subtracted the block mean and
concatenated across all blocks. Finally, we calculated voxel SDs across this
concatenated time series (5–7, 29).
Partial least-squares analysis. To examine multivariate relations between SDBOLD,
AMPH, age group, and task condition during n-back, we used a Task PLS analysis
(24). Task PLS begins by calculating a between-subject covariance matrix between
experimental conditions/groups and each voxel’s SDBOLD, which is then decom-
posed using singular value decomposition. This yields a left singular vector of
experimental condition/group weights (U), a right singular vector of brain voxel
weights (V), and a diagonal matrix of singular values (S). This analysis produces
orthogonal LVs that optimally represent relations between experimental condi-
tions/groups and voxelwise SDBOLD values. To obtain a summary measure of each
participant’s expression of a particular LV’s spatial pattern, we calculated within-
person “brain scores” by multiplying the vector of brain weights (V) from each
LV by within-subject vectors of voxel SDBOLD values (separately for each condition/
group within person). Significance of detected relations between multivariate
spatial patterns and conditions/groups was assessed using 1,000 permutation
tests of the singular value corresponding to each LV. A subsequent bootstrapping
procedure revealed the robustness of voxel saliences across 1,000 bootstrapped
resamples of the data (48). By dividing each voxel’s mean salience by its boot-
strapped SE, we obtained “bootstrap ratios” (BSRs) as normalized estimates of
robustness. We thresholded BSRs at a conservative value of ±4.25, which exceeds
a 99.99% confidence interval. See SI Methods for further details.
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